Literature DB >> 28017968

Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.

F Arruga1,2, B Gizdic1,2, C Bologna1,2, S Cignetto1,2, R Buonincontri1,2, S Serra1,2, T Vaisitti1,2, K Gizzi1, N Vitale3, G Garaffo3, E Mereu3, F Diop4, F Neri1, D Incarnato1, M Coscia3, J Allan5, R Piva3, S Oliviero1,6, R R Furman5, D Rossi4, G Gaidano4, S Deaglio1,2.   

Abstract

Even if NOTCH1 is commonly mutated in chronic lymphocytic leukemia (CLL), its functional impact in the disease remains unclear. Using CRISPR/Cas9-generated Mec-1 cell line models, we show that NOTCH1 regulates growth and homing of CLL cells by dictating expression levels of the tumor suppressor gene DUSP22. Specifically, NOTCH1 affects the methylation of DUSP22 promoter by modulating a nuclear complex, which tunes the activity of DNA methyltransferase 3A (DNMT3A). These effects are enhanced by PEST-domain mutations, which stabilize the molecule and prolong signaling. CLL patients with a NOTCH1-mutated clone showed low levels of DUSP22 and active chemotaxis to CCL19. Lastly, in xenograft models, NOTCH1-mutated cells displayed a unique homing behavior, localizing preferentially to the spleen and brain. These findings connect NOTCH1, DUSP22, and CCL19-driven chemotaxis within a single functional network, suggesting that modulation of the homing process may provide a relevant contribution to the unfavorable prognosis associated with NOTCH1 mutations in CLL.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28017968     DOI: 10.1038/leu.2016.383

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  39 in total

1.  Regulation of STAT3-mediated signaling by LMW-DSP2.

Authors:  Y Sekine; S Tsuji; O Ikeda; N Sato; N Aoki; K Aoyama; K Sugiyama; T Matsuda
Journal:  Oncogene       Date:  2006-04-24       Impact factor: 9.867

2.  De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.

Authors:  Masahiro Oka; Amy M Meacham; Takashi Hamazaki; Nemanja Rodić; Lung-Ji Chang; Naohiro Terada
Journal:  Oncogene       Date:  2005-04-28       Impact factor: 9.867

3.  NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Authors:  F Pozzo; T Bittolo; F Arruga; P Bulian; P Macor; E Tissino; B Gizdic; F M Rossi; R Bomben; A Zucchetto; D Benedetti; M Degan; G D'Arena; A Chiarenza; F Zaja; G Pozzato; D Rossi; G Gaidano; G Del Poeta; S Deaglio; V Gattei; M Dal Bo
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

4.  The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

Authors:  T Vaisitti; V Audrito; S Serra; R Buonincontri; G Sociali; E Mannino; A Pagnani; A Zucchetto; E Tissino; C Vitale; M Coscia; C Usai; C Pepper; V Gattei; S Bruzzone; S Deaglio
Journal:  Leukemia       Date:  2014-07-03       Impact factor: 11.528

5.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

6.  CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.

Authors:  Silvia Buonamici; Thomas Trimarchi; Maria Grazia Ruocco; Linsey Reavie; Severine Cathelin; Brenton G Mar; Apostolos Klinakis; Yevgeniy Lukyanov; Jen-Chieh Tseng; Filiz Sen; Eric Gehrie; Mengling Li; Elizabeth Newcomb; Jiri Zavadil; Daniel Meruelo; Martin Lipp; Sherif Ibrahim; Argiris Efstratiadis; David Zagzag; Jonathan S Bromberg; Michael L Dustin; Iannis Aifantis
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

7.  HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells.

Authors:  Dongbo Liu; Peng Zhou; Li Zhang; Wei Gong; Gang Huang; Yingru Zheng; Fengtian He
Journal:  Biochemistry (Mosc)       Date:  2012-08       Impact factor: 2.487

8.  CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia.

Authors:  Gema Malet-Engra; Julien Viaud; Loïc Ysebaert; Manon Farcé; Fanny Lafouresse; Guy Laurent; Frédérique Gaits-Iacovoni; Giorgio Scita; Loïc Dupré
Journal:  Cancer Res       Date:  2013-05-03       Impact factor: 12.701

9.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

Review 10.  From fly wings to targeted cancer therapies: a centennial for notch signaling.

Authors:  Panagiotis Ntziachristos; Jing Shan Lim; Julien Sage; Iannis Aifantis
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more
  30 in total

1.  Effect of endovascular therapy on the expression levels of serum T lymphocyte subsets, Notch1 and TACE proteins in patients with abdominal aortic aneurysm.

Authors:  Hao Yan; Hong Jiang; Qian Xia; Wei Shan; Liwei Zhang; Fan Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.

Authors:  Francesca Arruga; Valeria Bracciamà; Nicoletta Vitale; Tiziana Vaisitti; Katiuscia Gizzi; Alison Yeomans; Marta Coscia; Giovanni D'Arena; Gianluca Gaidano; John N Allan; Richard R Furman; Graham Packham; Francesco Forconi; Silvia Deaglio
Journal:  Leukemia       Date:  2019-08-29       Impact factor: 11.528

3.  Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein.

Authors:  Noopur Bhore; Bo-Jeng Wang; Po-Fan Wu; Yen-Lurk Lee; Yun-Wen Chen; Wen-Ming Hsu; Hsinyu Lee; Yi-Shuian Huang; Ding-I Yang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

4.  Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.

Authors:  Huihuang Yan; Shulan Tian; Geffen Kleinstern; Zhiquan Wang; Jeong-Heon Lee; Nicholas J Boddicker; James R Cerhan; Neil E Kay; Esteban Braggio; Susan L Slager
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

5.  Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells.

Authors:  Yixin Zou; Hanning Tang; Yi Miao; Huayuan Zhu; Li Wang; Lei Fan; Jianxin Fu; Wei Xu; Jianyong Li; Yi Xia
Journal:  Chin Med J (Engl)       Date:  2022-04-20       Impact factor: 6.133

6.  Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.

Authors:  Maurizio Mangolini; Alba Maiques-Diaz; Stella Charalampopoulou; Elena Gerhard-Hartmann; Johannes Bloehdorn; Andrew Moore; Giorgia Giachetti; Junyan Lu; Valar Nila Roamio Franklin; Chandra Sekkar Reddy Chilamakuri; Ilias Moutsopoulos; Andreas Rosenwald; Stephan Stilgenbauer; Thorsten Zenz; Irina Mohorianu; Clive D'Santos; Silvia Deaglio; Daniel J Hodson; Jose I Martin-Subero; Ingo Ringshausen
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

7.  High-resolution Melting Analysis for NOTCH1 c.7541-7542delCT Mutation in Chronic Lymphocytic Leukemia: Prognostic Significance in Egyptian Patients.

Authors:  Dalia Sherief; Asmaa Hassan; Eman Habeeb; Nahla Nosair; Maaly Mabrouk; Sarah Shoeib; Heba Reyad; Tamer Haydra; Mona Watany
Journal:  Indian J Hematol Blood Transfus       Date:  2022-04-11       Impact factor: 0.915

8.  Discovery of Candidate DNA Methylation Cancer Driver Genes.

Authors:  Heng Pan; Loïc Renaud; Ronan Chaligne; Johannes Bloehdorn; Eugen Tausch; Daniel Mertens; Anna Maria Fink; Kirsten Fischer; Chao Zhang; Doron Betel; Andreas Gnirke; Marcin Imielinski; Jérôme Moreaux; Michael Hallek; Alexander Meissner; Stephan Stilgenbauer; Catherine J Wu; Olivier Elemento; Dan A Landau
Journal:  Cancer Discov       Date:  2021-05-10       Impact factor: 39.397

9.  Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.

Authors:  Cristina Bagacean; Christelle Le Dantec; Christian Berthou; Adrian Tempescul; Hussam Saad; Anne Bordron; Mihnea Zdrenghea; Victor Cristea; Nathalie Douet-Guilbert; Yves Renaudineau
Journal:  Clin Epigenetics       Date:  2017-11-28       Impact factor: 6.551

10.  Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression.

Authors:  José Luis Ordóñez; Jesús-María Hernández-Rivas; Miguel Quijada-Álamo; María Hernández-Sánchez; Ana-Eugenia Rodríguez-Vicente; Claudia Pérez-Carretero; Alberto Rodríguez-Sánchez; Marta Martín-Izquierdo; Verónica Alonso-Pérez; Ignacio García-Tuñón; José María Bastida; María Jesús Vidal-Manceñido; Josefina Galende; Carlos Aguilar; José Antonio Queizán; Isabel González-Gascón Y Marín; José-Ángel Hernández-Rivas; Rocío Benito
Journal:  Blood Cancer J       Date:  2021-07-09       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.